ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,944.68
-0.20%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Catabasis Pharmaceuticals Inc (CATB)

  7. Catabasis Pharmaceuticals Inc (CATB) ニュース

CATB

Catabasis Pharmaceuticals (CATB)

Catabasis Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CATB
日付受信時刻ニュースソース見出しコード企業名
2023/06/0621 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/05/2419 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/05/1205 : 11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/2105 : 05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/2105 : 04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/1921 : 11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/1921 : 09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/0705 : 01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/03/3121 : 00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/03/2221 : 09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1505 : 46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1505 : 04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1422 : 28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1420 : 02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/01/1102 : 49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/01/0522 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/2306 : 03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/2206 : 31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/2204 : 13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/1607 : 17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/1520 : 35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/11/1106 : 15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/11/1106 : 06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/11/1106 : 02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CATB

最近閲覧した銘柄

USOTC
CITZ
Citizens Bancshares Corp... (PK)
NYSE
WEC
WEC Energy
COIN
RUCEUR
ASX
SWMKOQ
USOTC
HIZOF
Hitachi Zosen (PK)
LSE
A2D1
A2d Fund. 22
COIN
MLGCGBP
LSE
40XQ
Gracech.crd 29
TSXV
RIV
Canopy Rivers
NASDAQ
MTTR
Matterport
ASX
IREKOQ
BIT
S29613
Societe Generale Effekten
USOTC
CLRD
Clearday (QX)
LSE
QL55
Morg.st.b.v 25
LSE
STAF
Staffline
NASDAQ
SGBX
Safe and Green
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有